C-Reactive Protein and Ischemia in Users and Nonusers of β-Blockers and Statins
Authors:
- 21 January 2003
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (2) , 245-250
Abstract
Background— Elevated levels of C-reactive protein (CRP) are associated with an increased risk of coronary events, but whether inflammation is associated with inducible ischemia in patients with stable coronary disease is unknown. Methods and Results— We recruited patients with known coronary disease from 2 VA Medical Centers and 1 University-based medical center for the Heart and Soul Study. We measured CRP levels in 118 participants who had exercise-induced ischemia and in 111 who did not have inducible ischemia, as determined by stress echocardiography. We used logistic regression to examine the risk of exercise-induced ischemia associated with elevated CRP. We found that 75% (39/52) of participants in the highest CRP category (>0.38 mg/dL) had inducible ischemia, compared with 45% (79/177) in the lower 4 categories combined (adjusted odds ratio 4.2; 95% confidence interval 1.6 to 11; P =0.004). However, this association differed in users and nonusers of β-blockers and statins. Among 89 participants who did not use β-blockers, 93% in the highest CRP category had exercise-induced ischemia, compared with 42% in the lower 4 categories ( P =0.03). Among 67 participants who did not use statins, 94% in the highest CRP category had exercise-induced ischemia, compared with 44% in the lower 4 categories ( P =0.009). We did not observe a significant association between CRP and ischemia among participants who were treated with either of these medications. Conclusion— Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with β-blockers or statins.Keywords
This publication has 31 references indexed in Scilit:
- Inflammation and AtherosclerosisCirculation, 2002
- Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular DiseaseCirculation, 2002
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the ElderlyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery diseaseJACC, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectorisThe American Journal of Cardiology, 1990
- Angiographic progression of coronary artery disease and the development of myocardial infarctionJACC, 1988